Dalton Travis

CEO Dalton Travis buys 20,920 shares at $12.36 blended price; stock down 78.2% from 52-week high and -31.4% in 90 days.

Dalton Travis, Pres., CEO & Executive Chair, executed 2 separate purchases totaling 20,920 shares for $258,638.40 on 2026-05-18, bringing his holdings to 45,872 shares and raising his position by 83.8%. The purchases occurred at a blended average price of $12.36, during a period when the stock trades at $16.17 (current), down 78.2% from its 52-week high of $74.07 and down 31.4% over the past 90 days. At CTEV specifically, Travis has a mixed timing record: 4 of 5 prior buys showed positive 90-day returns, with his most recent buy on 2026-02-27 returning +19.6% over 30 days. However, his cross-ticker track record shows strong performance (85.71% win rate, avg 90d return +351.2% across 7 buys), raising the question of whether his timing skill translates to CTEV. The company itself is unprofitable (net income of $-73,560,000.00 in the latest quarter, negative full-year net income), with modest 3.7% annual revenue growth. The magnitude of this buy relative to his prior holdings and the sharp stock decline warrant attention to whether this reflects fundamental conviction or simply an accumulation during depressed valuation levels.

CEO Dalton Travis buys 15,380 shares at $13.00; stock down -80.1% from $72.58 52-week high; company unprofitable with -$69.8M net income

Dalton Travis, as President, CEO & Executive Chair, purchased 15,380 shares at $13.00 on 2026-02-27, increasing his holdings from 9,572 shares to 24,952 shares (+160.7% growth in his position). The transaction occurs while CTEV trades at $14.43, which is -80.1% from its 52-week high of $72.58, and the stock has declined -46.9% over 30 days and -68.0% over 90 days. Despite this dramatic drawdown, the company remains unprofitable with net income of -$69.8M on revenue of $245.9M. At the same-ticker level, Travis's prior four of five purchases showed positive 90-day returns (timing success rate of 80%), with his most recent CTEV buy on 2025-11-20 declining -50.1% over 90 days—a notable miss. The buy also coincides with a cluster pattern: 2 other insiders purchased within the past 14 days, suggesting broader management confidence despite deteriorating fundamentals and severe price deterioration. The concentration of this purchase into a deeply depressed valuation, combined with multi-insider buying activity during a period of sustained losses, warrants close monitoring of whether management's conviction in a turnaround has materialized.

CEO Dalton Travis bought 5,290 shares of CTEV at $47.23 (-37.7% from 52-week high); holding up 123.5%, clustering with 3 other insiders in past 14 days

Dalton Travis, the CEO, purchased 5,290 shares on 2025-11-20 at $47.23 for a total value of $249,841.94, increasing his holdings from 4,282 to 9,572 shares (a 123.5% increase). The purchase occurs at -37.7% from the 52-week high and follows sharp recent declines (-31.5% over 30 days, -37.3% over 90 days). His prior trades at CTEV show a consistent pattern of well-timed accumulation: all 4 prior buys registered positive 90-day returns (ranging from +4.2% to +165.6%), and his cross-ticker track record across 5 prior buys averaged +496.5% 90-day returns with a 100% win rate. The transaction is part of a cluster buy pattern, with 3 other insiders also purchasing within the past 14 days. Notably, the company is unprofitable, with $-69.8M net income in the latest quarter and -3.2% annual revenue growth, presenting a contrarian signal: concentrated insider accumulation during both a sharp stock decline and deteriorating fundamentals.

CEO Dalton Travis bought 4,282 shares in 2 purchases for $248,420.66, entering from zero shares as stock up 41.8% in 30 days.

Dalton Travis, President, CEO & Executive Chair of Claritev Corp, acquired 4,282 shares (4.3K shares) via two open-market purchases on 2025-08-08 and 2025-08-11, with a blended average price of $58.02, after holding zero shares pre-transaction. The stock has appreciated 41.8% over the prior 30 days and 144.6% over 90 days, currently trading at $65.70 (+0.0% from its 52-week high). Notably, Travis's cross-ticker track record shows a 100.00% 90-day win rate with an average 90-day return of +1141.9% across 3 prior open-market buys on other securities, though same-ticker outcomes are more limited: his prior CTEV purchase on 2025-03-07 delivered +100.0% over 90 days, and his May 2025 buy is showing +40.0% at 30 days. The company's fundamentals show ongoing unprofitability (net income $-62.6M on revenue of $241.6M, with annual revenue decline of -3.2%), creating a contrast between management's new equity commitment and deteriorating operational results.

CEO Dalton Travis bought 3.8K shares of CTEV at $26.50 ($100.0K); 2 other insiders bought within 14 days amid 30-day +34.7% rally and unprofitable fundamentals.

Dalton Travis, as President, CEO and Executive Chair, purchased 3,773 shares at $26.50 on 2025-05-15, expanding his holdings from 239.3K to 243.1K shares. The transaction occurred near the stock's 52-week high of $27.38 and during a sharp 30-day rally of +34.7%, raising a question about timing relative to the company's underlying financial position. The company generated revenue of $231.3M in its latest quarter but reported a net loss of $-71.3M, with annual revenue declining 3.2% year-over-year—fundamentals that stand in tension with both the recent price surge and the executive's buy decision. A cluster pattern is evident: 2 other insiders also purchased within the past 14 days, suggesting coordinated conviction or response to a common signal, though the motive remains opaque given the unprofitable operational context and elevated valuation.

CEO Dalton Travis purchased 5,252 shares of CTEV at $19.20, now valued at $17.35

Dalton Travis, serving as President, CEO & Executive Chair, acquired 5,252 shares at $19.20 on 2025-03-07 for a total value of $100,822.64, increasing his holdings from 234,033 to 239,285 shares (+2.2%). The purchase price of $19.20 is notably above the current market price of $17.35 as of 2025-03-10, representing an immediate unrealized loss on the transaction. This timing coincides with CTEV being a recent listing (7 trading days post-IPO), a period marked by price volatility and the absence of historical context. The company faces significant headwinds: it reported a net loss of $391.4M on revenue of $230.5M in its latest quarter and shows annual revenue decline of -3.2%, with the company unprofitable over its most recent full fiscal year. The CEO's purchase during early public trading and amid deteriorating fundamentals warrants investor attention to understand whether this represents opportunistic buying or positions the executive at financial risk.

CEO Travis buys 500,000 shares of MPLN at $0.37; stock down 86.6% from 52-week high, company posted $-576.7M net loss

Dalton Travis, President and CEO, purchased 500,000 shares at $0.37, increasing his holdings from 4,504,504 to 5,004,504 shares, a net increase of 11.1%. This transaction occurs amid severe deterioration in the company's financial position: MultiPlan posted a net loss of $-576.7M in its most recent fiscal year, revenue declined 11.0% year-over-year, and the stock has dropped 86.6% from its 52-week high of $84.40 to the current price of $11.28. The purchase at $0.37 represents an acquisition at an extreme discount to current market price. Notably, 2 other insiders also bought within the past 14 days, forming a cluster buy pattern that suggests coordinated confidence among the executive team during a period of acute financial stress and shareholder value destruction.